President And Ceo, Co-Founder
CurrentLaurent Pharmaceuticals is a clinical-stage biopharmaceutical company developing LAU-7b, a small molecule drug targeting host cells membrane lipids involved in antiviral defense, inflammation, and fibrosis. LAU-7b is being evaluated in clinical trials as a potential treatment for Cystic Fibrosis, IPF and Long COVID. See more at www.laurentpharma.com